Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

WHO Warns of Widespread Misunderstanding of Superbug Threat

Kate Kelland  |  November 17, 2015

LONDON (Reuters)—People across the world are confused about the major threat to public health posed by drug-resistant superbugs and do not know how to stop that risk growing, the World Health Organization (WHO) said on Monday.

Ramping up its fight against antibiotic resistance with a survey of public awareness, the United Nations health agency said 64% of those asked believed wrongly that penicillin-based drugs and other antibiotics can treat colds and flu, despite the fact such medicines have no impact on viruses.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Around a third of people surveyed also wrongly believed they should stop taking antibiotics when they feel better, rather than completing the prescribed treatment course, the WHO said.

“The findings … point to the urgent need to improve understanding around antibiotic resistance,” said Keiji Fukuda, the WHO’s special representative for antimicrobial resistance.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“One of the biggest health challenges of the 21st century will require global behavior change by individuals and societies.”

Over-use and misuse of antibiotics are the drivers of antibiotic resistance. Superbug infections—including multi-drug-resistant forms of tuberculosis, typhoid and gonorrhea—kill hundreds of thousands of people a year, and the trend is growing.

“The rise of antibiotic resistance is a global health crisis,” the WHO’s director-general Margaret Chan said in a statement. “It is reaching dangerously high levels in all parts of the world.”

The WHO surveyed 10,000 people across 12 countries—Barbados, China, Egypt, India, Indonesia, Mexico, Nigeria, Russia, Serbia, South Africa, Sudan and Vietnam—and found many worrying misconceptions.

Three quarters of respondents wrongly think antibiotic resistance means the body is resistant to the drugs.

Some 66% believe individuals are not at risk of a drug-resistant infection if they personally take their antibiotics as prescribed. An equal number thinks antibiotics can be used to treat viral infections and one third think they can stop taking antibiotics when they feel better rather than taking the full course, a practice that contributes to antibiotic resistance.

The WHO survey was released today to coincide with the first World Antibiotic Awareness Week, Nov. 16–22.

The WHO has launched a campaign, “Antibiotics: Handle With Care,” to increase awareness of global antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.

Share: 

Filed under:Drug Updates Tagged with:antibioticsdrug-resistant superbugInternationalWorld Health Organization

Related Articles
    The Patient's Choice

    When Rheumatologists Are a Patient’s Second or Third Choice for Medical Opinion

    September 7, 2016

    Outside Exam Room No. 5, the chart rack was empty, so I assumed my new consult was late. Just in case, I looked back over my shoulder as I passed by the partially open door and glimpsed the lower half of a woman holding a three-ringed binder on her lap. I squinted and took a…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    Updated Clinical Practice Guidelines for Lyme Disease, Lyme Arthritis

    February 16, 2021

    A team of healthcare practitioners and researchers, spearheaded by the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN) and the ACR, has developed updated evidence-based clinical practice guidelines for the prevention, diagnosis and treatment of Lyme disease. The 2020 guidelines cover a wide variety of Lyme disease manifestations, including Lyme arthritis. Linda…

    Treating Asymptomatic Hyperuricemia Could Lower Risk of Developing Chronic Conditions

    August 12, 2016

    When uric acid becomes elevated in the human body, a variety of problems can develop, most notably gout—a painful, inflammatory arthritis caused by uric acid crystal deposition in joints. Chronically elevated uric acid can also lead to painful kidney stones. The majority of patients found to have hyperuricemia, however, never go on to develop gout…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences